News & Resources

Engaged Capital Makes Headlines Following Agreement with HeartWare and HeartWare’s Termination of Valtech Acquisition

February 1, 2016

The Boston Business Journal, StreetInsider, Reuters and other media publications have reported on the agreement reached between Olshan client Engaged Capital, LLC and HeartWare International, Inc. following HeartWare’s termination of its proposed acquisition of Valtech Cardio. Engaged Capital had previously launched a proxy campaign in opposition to HeartWare’s acquisition of Valtech and nominated director candidates for election to HeartWare’s Board of Directors. Pursuant to the agreement, Engaged Capital and HeartWare will jointly select an additional independent director to be appointed to HeartWare’s Board and HeartWare agreed to form a business strategy committee. Steve Wolosky, Aneliya S. Crawford, Meagan Reda, Ryan P. Nebel and Bachar Mahmoud represented Engaged Capital in connection with its investment in HeartWare.